4//SEC Filing
Melrose Glenn R 4
Accession 0001474064-13-000047
CIK 0000890465other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:29 PM ET
Size
8.1 KB
Accession
0001474064-13-000047
Insider Transaction Report
Form 4
Melrose Glenn R
SVP, Human Resources
Transactions
- Award
Employee Stock Options (right to buy)
2013-02-13+49,005→ 49,005 totalExercise: $8.23Exp: 2023-02-13→ Common Stock (49,005 underlying) - Award
Restricted Stock Units
2013-02-13+18,226→ 18,226 total→ Common Stock (18,226 underlying)
Footnotes (3)
- [F1]Stock options granted under NPS Pharmaceuticals Inc.'s (the "Issuer") amended and restated 2005 Omnibus Incentive Plan (the "Plan"). The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 6.25% every three months thereafter.
- [F2]Each restricted stock unit was awarded under the Plan and represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Restricted Stock Units awarded under the Plan will vest as follows: (i) one third will vest on the first anniversary of date of grant, one third on the second anniversary of date of grant, and one third on the third anniversary of date of grant. Vested shares will be delivered to the reporting person as soon as administratively practicable following the vesting of the Restricted Stock Units.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeother
Related Parties
1- filerCIK 0001332933
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:29 PM ET
- Size
- 8.1 KB